ChemBriefAsahi Kasei Acquires German Biopharma Company Aicuris
Asahi Kasei signed an agreement to acquire German biopharma firm Aicuris for approximately €780 million, expanding its infectious disease platform with completion expected in Q2 2026. The transaction
ccin · 2026-03-03 00:00